Anne Prévötat

1.9k total citations · 1 hit paper
25 papers, 853 citations indexed

About

Anne Prévötat is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anne Prévötat has authored 25 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 5 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Anne Prévötat's work include Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (4 papers). Anne Prévötat is often cited by papers focused on Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (4 papers). Anne Prévötat collaborates with scholars based in France, Australia and Greece. Anne Prévötat's co-authors include B. Wallaert, Sylvie Leroy, Julia Salleron, Laurence Delhaès, Télesphore Sime‐Ngando, Christine Hubans, Éric Viscogliosi, Eduardo Dei‐Cas, F. Wallet and Magali Chabé and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Respiratory Medicine.

In The Last Decade

Anne Prévötat

22 papers receiving 840 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

2021 148 citations Pierre‐Régis Burgel, I. Durieu et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Anne Prévötat

Since Specialization

Citations

This map shows the geographic impact of Anne Prévötat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Prévötat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Prévötat more than expected).

Fields of papers citing papers by Anne Prévötat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Prévötat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Prévötat. The network helps show where Anne Prévötat may publish in the future.

Co-authorship network of co-authors of Anne Prévötat

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Prévötat. A scholar is included among the top collaborators of Anne Prévötat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Prévötat. Anne Prévötat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study 2024 ·Journal of Diabetes and its Complications ·(unknown), Laurence Weiss, François Lefèbvre, Michele Porzio, B. Renaud-Picard, (unknown), Michel Abély, Isabelle Danner‐Boucher, Séverine Dubois, Françoise Troussier, Anne Prévötat, G. Rault, Romain Kessler, Laurence Kessler	2
2	Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease breakdown → 2021 ·American Journal of Respiratory and Critical Care Medicine ·Pierre‐Régis Burgel, I. Durieu, R. Chiron, Sophie Ramel, Isabelle Danner‐Boucher, Anne Prévötat, Dominique Grenet, Christophe Marguet, Martine Reynaud‐Gaubert, Julie Macey, Laurent Mély, Annlyse Fanton, S. Quétant, Lydie Lemonnier, Jean-Louis Paillasseur, Jennifer Da Silva, Clémence Martin	148
3	First Wave of COVID-19 in French Patients with Cystic Fibrosis 2020 ·Journal of Clinical Medicine ·Harriet Corvol, Sandra de Miranda, Lydie Lemonnier, Astrid Kemgang, (unknown), R. Chiron, Marie‐Laure Dalphin, I. Durieu, J.‐C. Dubus, Véronique Houdouin, Anne Prévötat, Sophie Ramel, (unknown), Laurence Weiss, Loïc Guillot, Pierre‐Yves Boëlle, Pierre‐Régis Burgel	24
4	Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis 2020 ·ERJ Open Research ·(unknown), Maéva Kyheng, Olivier Le Rouzic, T. Pérez, B. Wallaert, Anne Prévötat	0
5	Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis 2019 ·American Journal of Respiratory and Critical Care Medicine ·Pierre‐Régis Burgel, À. Munck, I. Durieu, R. Chiron, Laurent Mély, Anne Prévötat, M. Murris‐Espin, Michele Porzio, Michel Abély, Philippe Reix, Christophe Marguet, Julie Macey, Isabelle Sermet‐Gaudelus, Harriet Corvol, S. Bui, Lydie Lemonnier, Clémence Dehillotte, Jennifer Da Silva, Jean-Louis Paillasseur, D. Hubert	92
6	Fertility of women with cystic fibrosis: a French survey 2019 ·Reproductive BioMedicine Online ·(unknown), (unknown), Anne Prévötat, Annlyse Fanton, (unknown), Jean Parinaud	9
7	Impact ofAchromobacter xylosoxidansisolation on the respiratory function of adult patients with cystic fibrosis 2019 ·ERJ Open Research ·(unknown), Florent Wallet, Maéva Kyheng, Sylvie Leroy, T. Pérez, Olivier Le Rouzic, B. Wallaert, Anne Prévötat	29
8	High airborne level of Aspergillus fumigatus and presence of azole-resistant TR34/L98H isolates in the home of a cystic fibrosis patient harbouring chronic colonisation with azole-resistant H285Y A. fumigatus 2019 ·Journal of Cystic Fibrosis ·(unknown), Sophie Lejeune, (unknown), Anne Prévötat, (unknown), Émilie Fréalle	3
9	Improvement in body composition following a supervised exercise-training program of adult patients with cystic fibrosis 2019 ·Respiratory Medicine and Research ·Anne Prévötat, J.F. GODIN, (unknown), T. Pérez, Olivier Le Rouzic, B. Wallaert	16
10	An educational intervention about the classification of penicillin allergies: effect on the appropriate choice of antibiotic therapy in pregnant women 2019 ·International Journal of Obstetric Anesthesia ·(unknown), D. Subtil, (unknown), Bruno Grandbastien, C. Catteau, (unknown), (unknown), Anne Prévötat, P. Richart, Karine Faure, Rémi Le Guern	5
11	The immediate effects of a single autogenic drainage session on ventilatory mechanics in adult subjects with cystic fibrosis 2018 ·PLoS ONE ·(unknown), T. Pérez, Anne Prévötat, Grégory Reychler, B. Wallaert, Olivier Le Rouzic	7
12	Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease 2017 ·Journal of Cystic Fibrosis ·D. Hubert, R. Chiron, B. Camara, Dominique Grenet, Anne Prévötat, Laurence Bassinet, S. Dominique, G. Rault, Julie Macey, Isabelle Honoré, Reem Kanaan, Sylvie Leroy, Nadine Dufeu, Pierre‐Régis Burgel	72
13	Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases 2017 ·PLoS ONE ·(unknown), Sara Gonzalez-Hilarion, Séverine Amand, (unknown), Anne Prévötat, Philippe Reix, D. Hubert, Éric Adriaenssens, Sylvie Rebuffat, David Tulasne, Fabrice Lejeune	19
14	Biphasic lung injury during Streptococcus pneumoniae infection in a murine model 2017 ·Médecine et Maladies Infectieuses ·Anne Prévötat, (unknown), Philippe Gosset, Éric Kipnis, Karine Faure, Benoît Guéry	4
15	Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis 2017 ·Respiratory Medicine ·Caroline Périsson, (unknown), Dominique Grenet, Laurence Bassinet, J. Derelle, Isabelle Sermet‐Gaudelus, C. Thumerelle, Anne Prévötat, (unknown), Annick Clément, Harriet Corvol	27
16	Virus and cystic fibrosis: Rhinoviruses are associated with exacerbations in adult patients 2014 ·Journal of Clinical Virology ·Anne Goffard, (unknown), Julia Salleron, Stéphanie Herwegh, Ilka Engelmann, Claudine Pinel, Isabelle Pin, (unknown), Anne Prévötat, A. Dewilde, Laurence Delhaès	59
17	Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease 2014 ·BMC Pulmonary Medicine ·Jean Pastré, Anne Prévötat, Catherine Tardif, Carole Langlois, Alain Duhamel, B. Wallaert	49
18	The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management 2012 ·PLoS ONE ·Laurence Delhaès, Sébastien Monchy, Émilie Fréalle, Christine Hubans, Julia Salleron, Sylvie Leroy, Anne Prévötat, F. Wallet, B. Wallaert, Eduardo Dei‐Cas, Télesphore Sime‐Ngando, Magali Chabé, Éric Viscogliosi	282
19	Intérêt de l’association ceftazidime et aztréonam dans les exacerbations de mucoviscidose à Pseudomonas aeruginosa multirésistant 2010 ·Revue des Maladies Respiratoires ·Anne Prévötat, Sylvie Leroy, T. Pérez, F. Wallet, B. Wallaert	1
20	Épidémie de légionellose dans le Pas-de-Calais (2003-2004) : analyse descriptive et facteurs prédictifs d’une évolution défavorable 2008 ·Revue des Maladies Respiratoires ·Anne Prévötat, (unknown), (unknown), (unknown), Nicolas Van Grunderbeeck, Yazdan Yazdanpanah, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact